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                                                          AIM 
 
 
 
TO EVALUATE THE EPIDEMIOLOGY, PATIENT PROFILE, VESSEL 
INVOLVEMENT PATTERN, AND TO ASSESS THE TYPE OF TREATMENT 
GIVEN AND OUTCOME FOR ATHEROSCLEROTIC AORTOILIAC OCCLUSIVE 
(AOD) DISEASE IN A TERTIARY CARE HOSPITAL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                   OBJECTIVES   
 
 
 
 
1. To   evaluate the general characteristics of the patients presenting with 
Atherosclerotic aortoiliac occlusive disease (AOD)  
 
2. To evaluate    the anatomical   pattern of   vessel involvement based   on 
Angiogram or the arterial Doppler study, including multiple level 
occlusions. 
 
3. To determine the type of treatment given, whether conservative (including 
Antiplatelet therapy and chemical sympathectomy), endovascular 
radiological intervention or open (surgical) reconstruction.  
 
4. To evaluate the outcomes of these treatment modalities i.e., symptomatic 
relief as well as complication rates, in the view of underlying risk factors. 
 
  
        
 
                      
                        REVIEW OF LITERATURE 
 
 
       
       Development of vascular   surgery dates back to the   landmark   repair   of 
vessel by   Dr. Alexis Carrel (1).  The    surgeon caring   for   the   patient     with   
peripheral   vascular disease  needs  to    evaluate and   manage the   associated    
disorders  and  he has to  understand and assess  the   risk management  more  
effectively in view of long term results,  whether it be management of the risk 
factors or deciding on an intervention, nonoperative or operative 
revascularization. 
 
 
Atherosclerosis 
 
       Atherosclerosis is a complex chronic inflammatory process that affects the 
elastic and muscular arteries.  The disease is both systemic and segmental, with 
clear predilections for certain locations within the arterial tree while sparing the 
others.  The earliest lesions (i.e., fatty streaks) may be detected as early as in the 
childhood in susceptible individuals (2). 
Lesions progress through a series of well-characterized pathologic stages before 
clinical manifestations develop. Hemodynamics plays an important role in the 
development of atherosclerosis. Low flow, flow recirculation, low mean wall shear 
stress, and oscillations in shear stress are hypothesized to play a role in the 
localization of atherosclerotic lesions in the carotid bifurcation, coronary arteries, 
and abdominal aorta 33. These low shear stress areas are hypothesized to be  
 more susceptible to cholesterol accumulation because of low local diffusional 
efflux from the arterial wall to the flowing blood and enhanced monocyte 
adhesion32. In contrast to the effects of low shear stress, increases in blood flow 
have been shown to stimulate the expression of nitric oxide synthase and 
superoxide dismutase, resulting in the reduction of cellular superoxide anion 
concentration and expression of monocyte chemotactic protein-1 and vascular 
cell adhesion molecule-134.  
 These effects reduce the adhesiveness of monocytes on the endothelium and 
are hypothesized to protect arteries from atherosclerotic plaques. Furthermore, 
elevated mean wall shear stress stimulates cellular structural changes, including 
cell elongation in the direction of maximum stress, inhibiting cholesterol 
accumulation from less permeable endothelial cell junctions 35. 
 
 Population based studies have demonstrated a number of important risk factors 
that have become targets for preventive therapy as well as potential clues into 
the pathogenesis of the disease. The influence of each of these risk factors on 
lower extremity arterial disease is discussed below. 
 
 
 
 
 
 Risk factors for atherosclerosis: 
 
Firmly established:  Hypertension        Relative factors:  Advanced age        
                                    Diabetes mellitus                            Male gender 
                                    Hypercholesterolemia                    Triglyceridaemia 
                                    Tobacco-consumption                   Homocysteinimia 
 
Hypertension: 
Hypertension has been repeatedly reconfirmed as the most potent force for 
developing the atherosclerotic diseases (3). Better blood pressure control has 
been demonstrated to reduce adverse end-organ effects on the vasculature.  For 
example, in a Meta analysis of 14 randomized trials of blood pressure control, the 
overall incidence of stroke was reduced 42% by a 5 – 6 mm Hg reduction in the 
diastolic blood pressure (4).  Equally important is the reduction of the blood 
pressure in high-risk population such as group of patients with peripheral 
vascular disease. 
In a study evaluating the results of Ramipril therapy in patients with and patients 
without peripheral arterial disease (Heart Outcomes Prevention Evaluation, 
HOPE, Study), the rate of the composite outcome of death from vascular causes, 
nonfatal myocardial infarction, and stroke was reduced in patients treated with 
ramipril; the outcomes did not differ significantly between patients with and 
patients without peripheral arterial disease. 
  
 
Horizontal bars denote 95 percent confidence intervals. In the graph, values 
below unity favor ramipril treatment. 
 
The atherogenic affect of hypertension is due to the high levels of Angiotensin II 
in these patients.  Angiotensin II stimulates the vascular smooth muscles to 
constrict as well as proliferate.  On the other hand, it stimulates the Lipo-
oxygenase pathway releasing the inflammatory mediators locally which trigger off 
the cycle of chronic inflammation and propagate the process of plaque  
 
formation (5).   However, it is not definitely known which antihypertensive drug can 
alter the clinical course, hypertension, likely to be present in vascular patients, 
should be identified and treated aggressively.   
 
 
Diabetes Mellitus: 
Atherosclerotic occlusive disease is a common complication of diabetes, 
accounting for 80% of the mortality rate (6).  An older study highlighted the 
problem by observing extremity gangrene to have occurred 53 times more 
frequently in diabetic men and 71 times more frequently in diabetic women than 
in their non-diabetic counterparts (7).  Most of the evidence points to a non-
occlusive thickening of the basement membrane of the vessel, which in turn 
impairs the exchange of nutrients and leucocytes between the capillary and 
interstitium. Furthermore, persons with diabetes have a sevenfold higher rate of 
lower extremity amputation than persons without diabetes.  However, the 
increased risk of amputation is likely multifactorial in origin and may be related to 
more distal and diffuse atherosclerosis among persons with diabetes, as well as 
concomitant peripheral sensory neuropathy that can lead to traumatic ulceration 
The disease is further complicated by the diabetic neuropathy predisposing to the 
development of foot ulcerations and infections in an already ischemic limb and 
hence the importance of maintaining euglycaemia in these patients.  Vascular 
complications affect the patients with both insulin dependent (type I) and non-
insulin dependent diabetes mellitus (type II) at an accelerated rate, as well as 
those with lesser glucose intolerance (8). 
Hence, strict medical control of the diabetes, with prompt wound-care 
management is essential in management of these patients. 
 
 
Tobacco: 
Tobacco smoking is the leading preventable cause of death, with its impact on 
three areas of concern: atherosclerotic vascular change, chronic obstructive 
pulmonary disease, and cancer. The association between smoking and lower 
extremity arterial disease may be, in fact even stronger than between smoking 
and coronary heart disease. All epidemiological studies of lower extremity arterial 
disease have confirmed cigarette smoking as a strong risk factor for development 
of lower extremity arterial disease, with relative risk ratios ranging from 1.7 to 7.5.  
The two main compounds identified to be responsible for the deleterious effects 
of tobacco consumption are Nicotine and Carbon monoxide.   
Presence of nicotine has shown increased number of vascular desquamation 
and endothelial cell death in addition to increased arterial injury-induced 
myointimal thickening.  Nicotine interferes with the Prostacyclin activity causing 
vasoconstriction and platelet aggregation, promoting the atherosclerotic plaque.  
The catecholamine surge increases intracellular lipid deposition, further 
complicating the pathogenesis of the disease. 
 
Carbon monoxide, on the other hand binds preferentially to the hemoglobin. It 
increases the hypoxic insult as well as permeability of the vessels and thus 
involved in the pathogenesis of atherosclerosis.    
Nearly all patients with peripheral vascular disease have atherosclerosis and 
about three of four affected patients are smokers.  The Framingham study clearly 
relates smoking to the development of intermittent claudication (9).  Follow up 
reports disclosed smoking as the major risk factor measured for atherosclerosis; 
results showed pronounced effects on claudication (10). Furthermore, a diagnosis 
of lower extremity arterial disease is made up to a decade earlier in smokers than 
in nonsmokers.  It is strongly suggested that a decrease in smoking can prevent 
progression of the disease process (11). 
 
 
 
Hyperlipidaemia: 
 
The principle importance of the dyslipidemias in clinical medicine derives 
primarily from their role in atherogenesis.  Abundant evidence is available 
establishing the strong association between various lipid disorders and 
atherosclerotic vascular disease (12, 13).  The processes that lead to the growth of 
atheromata in the coronary vessels are similar to those leading to atherosclerosis 
in the peripheral vasculature. Almost 50% of patients with lower extremity arterial 
disease have hyperlipidemia. In the Framingham Study a fasting cholesterol level 
>270 mg/dL (7 mmol/L) was associated with a doubling of the incidence of 
intermittent claudication. Although other studies have failed to confirm an 
association between lower extremity arterial disease and elevated cholesterol 
levels, there is evidence that treatment of hyperlipidemia reduces both 
progression of atherosclerosis in the peripheral arteries and incidence of 
intermittent claudication.  
Majority of case control studies have shown that and prospective studies have 
shown a positive correlation between serum triglyceride, LDL levels and coronary 
heart disease.   
Although not an independent factor, the presence of established atherosclerotic 
disease in non-coronary vessels must also be considered a risk factor for 
coronary heart disease (14).  
 
Age 
       The incidence of lower extremity arterial disease increases with age. For a 
man younger than 50, the prevalence of intermittent claudication is about 1% to 
2%, whereas for those older than 50, prevalence increases to about 5%. A similar 
trend is seen in women. Given these findings, it is likely that lower extremity 
arterial disease will become more common as life expectancy increases 
 
 
 
 
 
Male gender: 
       There has been significant difference between the two genders in the 
occurance of both atherosclerosis as well as its ill effects with respect to 
ischaemic damage in various systems. It has been observed that large-vessel 
peripheral artery disease is 50% more prevalent in men as compared with 
women before the age of 75 years29, and abdominal aortic aneurysms occur in 
six times as many men as women for all ages.  
 
Clinical Manifestations of lower limb ischaemia:  
       Approximately one third of patients with peripheral arterial disease have 
typical claudication, defined as pain in one or both legs on walking, primarily 
affecting the calves, that does not go away with continued walking and is relieved 
by rest. In patients with claudication, the severity of the condition increases 
slowly; 25 percent have worsening claudication, and 5 percent undergo an 
amputation within five years. Less than 5 to 10 percent of patients have critical 
leg ischemia (ischemic pain in the distal foot, ischemic ulceration, or gangrene), 
but their risk of limb loss is substantial. More than 50 percent of patients identified 
as having peripheral arterial disease on the basis of an abnormal ankle–brachial 
index value do not have typical claudication or limb ischemia at rest but, instead, 
have other types of leg pain on exertion, with reduced ambulatory activity and 
quality of life. Thus, most patients with peripheral arterial disease have a reduced 
functional capacity that limits their ability to perform daily activities.  
       The goals of treatment for patients with claudication are to relieve their 
exertional symptoms, improve their walking capacity, and improve their quality of 
life. These goals are similar for patients with critical leg ischemia, with the 
additional goals of relieving ischemic pain at rest, healing ischemic ulceration, 
and preventing limb loss. The overall approach to the diagnosis and treatment of 
peripheral arterial disease was extensively reviewed in a recent consensus 
publication that provides a comprehensive discussion of the medical and surgical 
therapies for the disease 36. 
 
 Natural history of Aortoiliac occlusive disease: 
       As mentioned above, knowledge of the natural history of lower extremity 
arterial disease is necessary when planning management strategies. When 
patients with intermittent claudication are followed for 5 years, about 50% either 
have no change in symptoms or may show improvement in functional status 
presumably due to development of collateral flow. Symptoms progress in about 
16% of these patients, and a full 25% will require. surgery or experience tissue 
loss. Less than 4% of patients require a major amputation (15).  In the 
Framingham Study only about 30% of patients with intermittent claudication had 
persistent symptoms for a minimum of 4 years.    
 
       The long-term amputation rate for patients with intermittent claudication is 
consistently less than 4%. For example, in two large population studies only 1.8% 
to 2.5% of patients diagnosed with intermittent claudication ever required a major 
amputation.  More recently, the estimated major amputation rate has been 
tabulated based on the results of two independent studies.  The major 
amputation rate in persons without diabetes ranged from 200 to 280 per million 
per year, whereas in persons with diabetes the rate was markedly higher at 3000 
to 3900 per million per year.  
 
        In one population-based study of patients with lower extremity arterial 
disease undergoing initial revascularization surgery, about 20% of patients 
eventually required an ipsilateral amputation, and 26% required at least one 
repeat ipsilateral revascularization procedure (17).  Patients undergoing aortoiliac 
or aortofemoral surgery were less likely to require amputation than patients with a 
more distal revascularization procedure were (26% versus 16%; P=.03).  
Risk of Systemic cardiovascular Ischemia. 
       Because patients with either asymptomatic or symptomatic lower extremity 
arterial disease have widespread arterial disease, they have a significantly 
increased risk of stroke, myocardial infarction, and cardiovascular death. At least 
10% of patients with lower extremity arterial disease have cerebrovascular 
disease, and 28% have coronary heart disease (16). 
 
Evaluation of the patient with chronic limb ischaemia: 
       The principle goals of evaluation of these patients are to determine the level 
of occlusion and the severity of the disease. 
 
 
         
        Evaluation of Patients in Whom Peripheral Arterial Disease Is Suspected. 
 
 
 
 
 
 
 
 
 
Objectives for Diagnostic Evaluation of Patients With Critical Limb Ischemia38  
The diagnostic evaluation of patients with critical limb ischemia should be 
directed toward the following objectives: 
 • Objective confirmation of the diagnosis 
 • Localization of the responsible lesion(s) and a gauge of relative 
severity 
 • Assessment of the hemodynamic requirements for successful 
revascularization (vis-à-vis proximal versus combined revascularization 
of multilevel disease) 
 • Assessment of individual patient endovascular or operative risk 
 
 
        A well-performed physical examination can often determine the proximal site 
or sites of involvement by obvious pulse deficits and the presence of a bruit at 
sites of narrowing. For example, absent foot and popliteal pulses indicate an 
occlusion proximal to the popliteal artery but tell the examiner nothing about the 
extent of disease below the knee. Before the availability of noninvasive testing, 
nothing more was usually done unless there was some indication for intervention 
to increase peripheral blood flow and relieve symptoms. However, with time and 
experience, it is now known that noninvasive testing can provide the physician 
with valuable information that can be used for both diagnostic and follow-up 
purposes.  
 
Diagnostic Tests: 
Pressure Measurements: Ankle-Brachial Index  
       With increasing degrees of arterial narrowing, there is a progressive fall in 
systolic blood pressure distal to the sites of involvement. This can be assessed 
using methods of indirectly measuring this pressure drop.  To accomplish this, a 
pneumatic cuff is applied to measure the pressure, and the sensing unit is placed 
distal to the cuff. The cuff is then rapidly inflated above systolic pressures, 
thereby obliterating flow to the part under study. As the pressure in the cuff is 
gradually deflated, the point at which flow is resumed is taken as the opening or 
systolic pressure at that level.  
 
       Normally, there is amplification of systolic pressure farther down the limb, ie, 
systolic pressure at the ankle level should be higher than that recorded from the 
upper arm.  This means that the systolic pressures recorded from both tibial 
arteries at the ankle should be at least equal to or higher than that recorded from 
the arm. Thus, the normal ABI should be 1.0. To account for variability in the 
measurement, it is generally agreed that a value of 0.95 is normal (18). For 
follow-up purposes, changes in the ABI within the range of ±0.15 are considered 
within the experimental error of the test, whereas changes outside this range are 
considered indicative of the disease process (19).  Assessment of the ABI helps to 
establish the diagnosis and also serves as a baseline measure for follow-up 
purposes. 
       Patients should be evaluated for peripheral arterial disease if they are at 
increased risk because of their age or the presence of atherosclerotic risk 
factors, have leg pain on exertion, or have distal limb ulceration for which the 
history and examination do not provide an obvious explanation. Additional 
vascular studies can be performed in patients with an ankle–brachial index value 
above 1.30, including pulse-volume recording, measurement of pressure in the 
first toe, or duplex ultrasonographic imaging of the peripheral vessels, to 
determine whether peripheral arterial disease is present. Patients with leg pain 
on exertion who have ankle–brachial index values of 0.91 to 1.30 should be 
considered for an exercise test. An ankle–brachial index value that is over 0.90 at 
rest but decreases by 20 percent after exercise is diagnostic of peripheral arterial 
disease. If the initial ankle–brachial index value is 0.90 or less at rest, the patient 
probably has peripheral arterial disease, and no additional tests are necessary. 
        ABI determinations may be of limited value in persons with diabetes, 
however, because calcification of the tibial and peroneal arteries may render 
them noncompressible. This is an important distinction because there is no 
relation between calcification and the extent of atherosclerotic disease within 
these arteries.   
       Another advantage of measuring ABI in elderly patients is that it is a 
surrogate measure of atherosclerosis throughout the body. Thus, an abnormal 
ABI is one of the best predictors of subsequent cardiovascular events. Because it 
is so simple to perform, it could well become a standard  
 
part of the physical examination of elderly patients and those who appear at risk 
for development of atherosclerosis 
 
Ultrasonic Duplex Scanning 
       The first study of the peripheral arterial circulation by duplex scanning was 
published in 1985 20. This study clearly showed that the method was as accurate 
in defining the location and severity of arterial lesions as were two radiologists 
reading arteriograms done in the same patients. Similar results have been 
obtained when the technique has been applied prospectively 21.  
       Color doppler alone can be used to estimate the degree of narrowing, and 
although not as precise, it does provide a rough index of disease severity. 
Normally there is a triphasic color response. Poststenotic turbulence and the 
presence of a bruit at the site of narrowing are indicative of >50% stenosis, 
whereas the complete absence of color and evidence of collateral arteries 
proximal to the site of obstruction suggest total occlusion 22. 
 
Peripheral Angiogram:  
       Contrast Angiogram, with digital subtraction (DSA), is an excellent study that 
helps in direct visual assessment of the level and extent of the disease and is 
considered gold standard in preoperative evaluation of arterial stenosis world 
wide 32.   
       The disadvantage of an angiogram is that it is an invasive procedure with 
attendant risks of contrast nephropathy, anaphylaxis, incidence of haematoma 
formation at the puncture site and dissection of the vessel being catheterized.  
Catheter related complications like inability to retrieve the delivery device 
necessitating open arterotomy to remove these have been frequently reported. 
       Magnetic resonance angiography (MRA) has recently become instrumental 
in the diagnosis of arterial disease in various body districts and is gaining an 
increasingly important role in the study of peripheral vascular lesions37. 
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Strategies in management of Atherosclerotic lower limb 
ischemia 
       Successful management of a patient with clinical and radiological features of 
atherosclerotic occlusive disease involves an overall perspective of the disease 
process and the patient factors. 
 
 
  
Non-operative management 
       The medical management of atherosclerosis is targeted to reduce the 
progression, induce regression, and prevent morbid end points of lesion 
formation.  Risk factor management is the primary approach 
 
AHA Guidelines for Risk Factor Modification:       (23) 
1. Smoking:  Complete cessation of all forms of tobacco consumption, 
including     chewing and sniffing.  Approach: behavior modification, 
counseling, nicotine analogues 
2. Weight reduction to less than 120% of the ideal body weight  
3. Blood pressure to be maintained below 140/90 mm of mercury. 
4. Lipid management:    primary – LDL < 100 mg/dl 
                                         Secondary – HDL > 35 AND TG < 200 mg/dl 
                                         Low fat diet, Specific drug therapy to target lipid 
profile 
5. Physical activity:  At last 30 minutes of moderate exercise 3-4 times a 
week. 
 
 
       Antiplatelet therapy constitutes the other major medical treatment option.  
The goal is to prevent thrombosis, embolisation, and perhaps even the 
progression of  atherosclerotic disease.  Aspirin remains the cornerstone of 
antiplatelet therapy here and large Meta analyses from the Antiplatelet Trialists, 
31 randomized trials involving more than 29 000 patients with vascular disease 
were analyzed and have clearly demonstrated the beneficial effects of Aspirin in 
patients with prior myocardial infarcts, carotid atheroembolism, and peripheral 
arterial surgery (24). 
       The newer Antiplatelet agents have been developed with an increased 
potency and specific antiaggregative effects like Ticlopidine and Clopidogrel 
which hane shown efficacy in reducing some cardiovascular endpoints. 
       Rheological agents like pentoxifylline has been reported to improve abnormal 
erythrocyte deformability, reduce blood viscosity, and decrease platelet reactivity 
and plasma hypercoagulability in experimental setup but may not be clinically 
important compared with the effects of placebo, and does not justify the added 
expense for most patients. 
       Cilostazol, which inhibits phosphodiesterase type 3, thereby increasing 
intracellular concentrations of cyclic AMP, prevents platelet aggregation, the 
formation of arterial thrombi, and vascular smooth-muscle proliferation and 
causes vasodilatation 
 
        Exercise therapy is based on the concept of breaking the disability cycle 
which most of these patients enter further worsening the clinical scenario. 
Prospective studies have demonstrated a benefit of exercise training in patients 
with claudication. Because most patients studied have had mild-to-moderate 
claudication, little is known about the clinical benefits of exercise in patients with 
asymptomatic peripheral arterial disease or in patients with critical leg ischemia. 
Although exercise-induced improvement in walking ability is well established, the 
magnitude of the responses to training across studies has varied. Such variability 
may be explained by study-specific differences in the intensity, duration, and 
frequency of the exercise prescription and the methods of measuring exercise 
capacity.  
       One meta-analysis that examined both nonrandomized and randomized trials 
showed that exercise training improved pain-free walking time in patients with 
claudication by an average of 180 percent and improved maximal walking time by 
an average of 120 percent. The greatest improvements in walking ability occurred 
when each exercise session lasted more than 30 minutes, when sessions took 
place at least three times per week, when the patient walked until near-maximal 
pain was reached, and when the program lasted six months or longer 
                                            
 
 The cycle of disability resulting from claudication, the mechanisms involved, and 
the role of exercise training are shown in the following figure: 
 
  Revascularisation 
       Indications for Revascularization in Intermittent Claudication as per 
recommendations of Trans Atlantic Inter-Society Consensus (TASC) Working 
Group : 
1.  A predicted or observed lack of adequate response to exercise 
therapy and claudication pharmacotherapies 
2.  Presence of a severe disability, either being unable to perform 
normal work or having very serious impairment of other activities 
important to the patient 
3. Absence of other disease that would limit exercise even if the   
claudication was improved (e.g., angina or chronic respiratory 
disease) 
4. The individual’s anticipated natural history and prognosis 
5.   The morphology of the lesion must be such that the appropriate         
intervention would have low risk and a high probability of initial and  
       long-term success. 
 
  
 
Accepted Treatments for Symptomatic Lower Extremity Atherosclerotic Occlusive 
Disease  
 
 
 
Surgical Endovascular Nonoperative 
Endarterectomy Transluminal angioplasty Risk factor modification 
Bypass grafting Endovascular stents Exercise 
AutogenousProsthetic Intra-arterial thrombolytic 
therapy 
Drugs (including thrombolytic 
agents) 
Amputation    
 
 
       To date, indications for surgical treatment of lower extremity ischemia have 
been defined in terms of severity of symptoms, with hemodynamic data serving 
to confirm the diagnosis but not as the primary indication for surgery. There is 
general agreement that surgical treatment is indicated to relieve symptoms of 
limb-threatening ischemia, including ischemic pain at rest, ischemic ulcers, and 
gangrene. There also is general agreement that surgery is indicated to remove or 
bypass and exclude sources of atheroemboli. On the other hand, currently, the 
primary indications for an interventional procedure in patients with lower extremity 
arterial disease include (1) incapacitating claudication interfering with work or 
lifestyle; (2) limb salvage in patients with limb-threatening ischemia as manifested 
by pain at rest, nonhealing ulcers, and/or infection or gangrene; and (3) 
vasculogenic impotence. 
  Interventional radiology 
       In recent years there has been a dramatic increase in the use of 
interventional radiological procedures for the treatment of acute and chronic 
lower extremity arterial disease. This reflects advances in vascular imaging that 
have made percutaneous transluminal angioplasty (PTA) more feasible, the 
development of intravascular stents, and the more widespread use of intra-
arterial thrombolysis for the treatment of peripheral arterial thrombosis. 
 
Percutaneous Transluminal Angioplasty  / Stent placement.  
       Although the majority of patients with symptomatic aortoiliac disease do not 
require an invasive intervention, for those with incapacitating claudication or limb-
threatening ischemia, angioplasty and lower extremity bypass surgery are the two 
major therapeutic options. Currently, the primary indications for an interventional 
procedure in patients with lower extremity arterial disease include (1) 
incapacitating claudication interfering with work or lifestyle; (2) limb salvage in 
patients with limb-threatening ischemia as manifested by pain at rest, nonhealing 
ulcers, and/or infection or gangrene; and (3) vasculogenic impotence.  
PTA is an appropriate choice only when two important criteria are met. These 
include arterial disease localized to a vessel segment <10 cm in length and the  
availability of a skilled vascular interventionalist25. Although data comparing 
surgery with PTA in patients with lower extremity arterial disease are limited, in a 
randomized trial (level II) that included 252 patients, there was no difference in 
clinical outcomes during a mean follow-up of 4 years26. 
       There is level V evidence suggesting that PTA of the iliac arteries is 
associated with better long-term success rates than more distal angioplasty27.  
Iliac PTA is useful not only for dilatation of primary lesions but also as an adjunct 
to definitive femoropopliteal surgery where success rates are high when the 
procedure is carefully performed. For example, in a level V case-series study of 
667 consecutive iliac PTA procedures done at the University of Toronto, initial 
success rates were as high as 90%. However, at 5 years the overall patency rate 
fell to 53%. The extent of disease at presentation influenced the long-term 
patency rate. Thus, in patients with isolated lesions in the common iliac arteries 
and good distal arteriographic run-off, the 5-year patency rate was 63%, whereas 
in those with poor run-off, it was only 51%. The complication rate was relatively 
low at 4%28. 
       It has been suggested that vascular stenting provides more durable vascular 
dilatation than simple PTA, particularly when the patient is at high risk for 
restenosis. Currently available intravascular stents are either balloon expandable 
(eg, the Palmaz and Strecker stents) or self-expandable (eg, the Wallsten and 
Gianturco stents). In 1990 the first large trial (level V) evaluating the Palmaz stent  
showed only a 2% stent thrombosis rate at 6 months, with almost 90% of patients 
experiencing some clinical benefit.  At present the role of stents in treatment of 
lower extremity arterial disease is unclear. Although stent placement is a 
reasonable adjunct to PTA when a dissection occurs or when the lesion is 
particularly complex, the role of stents in primary PTA has yet to be established. 
Operative revascularization: 
       There is general agreement that surgical treatment is indicated to relieve 
symptoms of limb-threatening ischemia, including ischemic pain at rest, ischemic 
ulcers, and gangrene. There also is general agreement that surgery is indicated 
to remove or bypass and exclude sources of atheroemboli.  In contrast, 
intermittent claudication is considered only a relative indication for surgical 
treatment and then only after an adequate trial of nonsurgical therapy. Presently 
there is no consensus regarding disease severity, whether assessed by 
symptoms or hemodynamic parameters, for which operative treatment of 
claudication is appropriate 29. 
 
 Various surgical procedures have been described to improve the inflow to the 
lowerlimbs in aortoiliac disease: 
-Aortobifemoral bypass                             -Femorofemoral bypass 
     -Aortoiliac or aortofemoral bypass            - Axillofemoral bypass 
    -Aorto / Iliac endarterectomy                     - Axillofemoral-femoral bypass 
  
       For aortoiliac disease the results of aortofemoral bypass and aortoiliac 
endarterectomy are equivalent with respect to patency.  Most surgeons prefer 
bypass because endarterectomy operations are longer, more technically 
demanding, and associated with greater blood loss. For elderly patients and 
those with increased operative risk, satisfactory results have been reported with 
extra-anatomic bypass grafting procedures (axillofemoral, femorofemoral) that 
avoid the physiological stress of aortic clamping and abdominal cavity surgery. 
Patency rates of extra-anatomic bypass grafting have historically been lower than 
those of aortofemoral grafting. 
       Choice of the operative procedure depends on the pattern of the vessel 
involved. Most commonly, patients demonstrate diffuse disease of the infrarenal 
aorta and iliac vessels, with the lesions of greatest hemodynamic consequence 
located in the iliac arteries. The most effective surgical procedure for the 
treatment for this pattern of atherosclerotic occlusive disease is aortobifemoral 
bypass. Aortobifemoral grafting is associated with an operative mortality of 3.3% 
and a morbidity of 8.3% 39. The expected patency of aortobifemoral bypass as the 
sole procedure for the treatment of critical limb ischaemia is excellent 39. 
If the aortoiliac lesions are confined to the area of the aortic bifurcation, localized 
aortoiliac endarterectomy may be considered. This procedure is effective but is 
uncommonly performed because few patients have such a limited manifestation 
of  atherosclerosis. Nonetheless, when the operation is indicated, the results 
demonstrate good patency, in the range of 48% to 77% at 10 years. 
       For patients with adequate aortic flow but stenoses or occlusions of both iliac 
vessels who are not considered acceptable candidates for aortobifemoral bypass, 
a somewhat less invasive approach may be appropriate. If 1 iliac artery can be 
made widely patent by angioplasty and stent placement, endarterectomy, or a 
unilateral iliofemoral bypass, a femoral-femoral bypass can be constructed. In the 
absence of an inflow stenosis within the donor iliac arterial segment, this 
procedure can effectively improve flow to both lower extremities. 
        Unilateral iliac stenoses or occlusions that cannot be treated effectively by 
angioplasty and stent placement can be treated by iliac artery endarterectomy, 
aorto-iliac bypass, aortofemoral bypass, or iliofemoral bypass if the origin of the 
iliac artery is free of disease.  
       The surgical treatment of unilateral iliac disease by aortoiliac, iliofemoral, or 
femoral-femoral bypass graft placement provides excellent results for the 
restoration of inflow into the lower extremity. Ipsilateral bypasses that originate 
from the aorta or proximal iliac artery have a 3-year patency rate in the range of 
90% 40. Femoral-femoral bypass grafting yields a 3-year patency rate that ranges 
from 60% to 80% and a 5-year patency rate of 60% to 90%  
Patients with severe infrarenal aortic atherosclerosis who are at high 
cardiovascular or surgical risk for open aorto-bifemoral bypass may be treated  
with axillofemoral-femoral bypass. Because this graft is based on the axillary 
artery, preoperative assessment of bilateral arm blood pressures, duplex 
ultrasound flow assessments, and/or imaging of the aortic arch and great vessels 
to the origin of the donor vessel should be obtained.  
       Axillofemoral and axillobifemoral grafts are significantly inferior to 
aortobifemoral bypass grafts or aortoiliac endarterectomy for the treatment of 
severe diffuse aortoiliac disease. The 5-year patency rate for axillofemoral grafts 
ranges from 19% to 50%.  The results of axillobifemoral bypass are somewhat 
better, with 5-year patency rates that range from 50% to 76% . 
       A comparison of surgical reconstruction with PTA for treatment of lower 
extremity ischemia in a level 2 study showed that the surgical group maintained 
slightly higher success rates, with the differences being explained almost entirely 
by the lower initial success rate of angioplasty. Successful angioplasty in this 
study was as durable as successful surgery30.  
The numerous options available for the treatment of aortoiliac occlusive disease 
have led to controversy over which is best. Not only are the technical aspects of 
direct aortoiliac reconstruction debated but the role of lower risk but less durable 
options such as extraanatomic bypass and balloon angioplasty and/or stenting is 
still unsettled. 
 Rather than yield to the tendency to apply one method preferentially over the 
others, it is important to realize that each approach has a selective role to play in 
the overall management of aortoiliac occlusive disease, if applied in appropriate 
settings 31. 
       An observational study was done, to evaluate the patients with 
atherosclerotic aortoiliac disease, in view of this background knowledge of the 
available literature, in an attempt to understand the disease process as well 
management strategies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
                                                        Methodology 
 
 
1. 20 patients with aortoiliac disease diagnosed clinically and proven with 
arterial doppler and or an angiogram were studied prospectively for an 
year. Also, 360 patients with peripheral vascular disease visiting our 
hospital for past nine years were evaluated, and data collected for 91 
patients with aortoiliac disease (total no.= 111).   
2. Epidemiological evaluation, risk factors, disease severity, treatment 
options and outcome was studied and analyzed using the SSPS 
software for windows. 
3. Frequency tables were drawn for each of the parameters using the 
statistical analysis and incidence of the variables in each category was 
calculated. 
4. Using this basic data sheet, all the variables were cross tabulated and 
evaluated based on their strength of association. 
5. Finally inferences were drawn and conclusion made based on the 
analysed data.  
 
 
 
 
 
 
 
              The patient factors studied were drawn up into a Vascular Proforma. 
 
 
                                                       PROFORMA 
 
 
1. Demography: Age , Gender 
2. Clinical presentation: Claudication, Rest pain, Gangrene, Acute ischemia,   
Ischemic ulcer 
3. Risk factors and co-morbidities: History of tobacco intake, Diabetes 
mellitus, Hypertension, Dyslipidaemia. 
4. Past treatment obtained: Conservative, Sympathectomy, 
Revascularization, Amputation/debridement. 
5. Clinical examination including general physical examination and 
examination of the affected limb(s) 
6. Ankle Brachial Pressure Index 
7. Angiogram and/ or Arterial color doppler findings: Level of obstruction. 
8. Management of the patient: Conservative,  Operative revascularization,  
Radiological intervention,    Amputation/debridement 
9. Morbidity   specific   to  the  management  strategy 
10. Outcome – Pain relief, Palpable pulse, Improvement in ABPI, Healing of 
the ulcer 
 
 
 
 
 
                                                        
 
                                                          RESULTS 
The results of this study are based on, as mentioned in the methodology,  
20 patients evaluated prospectively for one year and 91 patients evaluated 
retrospectively for the past 9 years, with a total of 111 patients, diagnosed to 
have atherosclerotic aortoiliac occlusive disease. 
Epidemiology 
1. Age: 
                   
age in y ears
85.0
80.0
75.0
70.0
65.0
60.0
55.0
50.0
45.0
40.0
35.0
30.0
25.0
30
20
10
0
Std. Dev = 9.79  
Mean = 55.7
N = 111.002
6
17
21
17
25
13
4
3
 
 
Increasing age was clearly shown to be associated with higher incidence of 
aortoiliac occlusive disease.  The mean age of presentation with symptomatic 
disease is 56 years 
In an age distribution analysis,   83% of the patients were in the 45 – 65 age 
group. 
 
2. Gender:  
                                      
90
10
Male
Female
                                               
                                                      Gender (%) 
Males had a significantly  higher preponderance to the disease with 90% of the 
patients being men. 
 
3. Presentation              
                                        
5.5
94.5
Acute ischamia
Chronic ishaemic
limb
 
      5.5 percent of the patients presented as acute ischemia while the rest 94.5 
presented with chronic illness. 
4. Symptoms in aortoiliac dasease:  
                      
64.8
35.2 Claudicants
CLI
 
Patients were regrouped into claudicants and those with critical limb ischemia 
based on their symptoms at present. 64.8% had critical limb ischemia while the 
rest 35.3% were in the claudication stage only.                                         
    Claudication was the principle symptom reported by the patients, occurring as 
either the only symptom or having experienced it before entering the critical 
ischemic state.  A non-healing ulcer was the next common symptom and almost 
same number of patients had rest pain, 39% and 37% respectively. About 29 % 
of the patients also had distal gangrene because of ischemia. 
   
5.Associated ischemic symptoms in other systems:   
 
      
 
 
 
 
 
   
15.3% of patients gave history of cardiac ischemia requiring treatment in the 
past. 10.8 % of the patients had impotence while another 9% had past episodes 
of a cerebral vascular event.  One patient reported symptoms suggestive of 
chronic mesenteric ischemia. 
 
6. Risk factors for Atherosclerotic arterial disease: 
 
 
 
 
     
 
  
 
 
 
System involved 
 
No 
 
Percentage 
 
Cardiac  
 
17 
 
15.3% 
 
Impotence 
 
12 
 
10.8% 
 
Cerebral  
 
 
10 
 
  9% 
 
Mesenteric 
 
 
1 
 
<1% 
Risk factor No. Pecentage 
Smoking 96 86.5% 
Diabetes mellitus 64 57.7% 
Hypertension 49 44% 
Dyslipidaemia 14 12.6% 
 
 
86.5% of the patient consumed tobacco in one form or the other making it the 
major risk factor for the atherosclerotic disease.   
57%  of the patients with lower limb ischaemia had Diabetes mellitus currently on 
treatment.  Hypertension was the next important risk factor found in 44%.  
Dyslipidaemia was seen in 12.6% of the subjects. 
 
7. Past treatment history  
         81% of the patients had received medical treatment prior to admission.  
These include analgesics, antiplatelet therapy. 8% of the patients had lumbar 
sympathectomy for pain relief and equal number already had some form of r 
revascularization done, either open surgical or radiological intervention. 
 
8.Clinical assessment 
                                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
 
 
Clinical Feature No. Percentage 
 
Undernourished 
 
70 
 
63% 
 
High blood pressure 
 
60 
 
54% 
 
Femoral pulse 
not palpable 
 
 
83 
 
 
75% 
 
Bruit 
 
13 
 
12% 
 
Trophic changes 
 
106 
 
95.5% 
 
Affected limb cold 
 
98 
 
88% 
 
                      
                        
       Clinical examination of the patient showed about 63% of the patients to be 
undernourished.  Blood pressure readings were high (>140/90 mm Hg) in 45.5%, 
which is marginally higher than the number of patients actually presented with 
hypertension (44%).   
In 75% of patients, the pulse was not palpable from femoral downward.  In rest of 
the patients, popliteal downward was not palpable with a weak femoral pulse.  
12% 0f them had an audible bruit.  Trophic changes in the affected limb, namely 
muscular atrophy, loss of hair, shiny skin etc, were seen in 95.5% and the limb 
was cold compared to the non-affected limb in 88% of the patients. 
 
9. Ankle Brachial Pressure Index  
 
 
 
 
 
 
 
 
   91% of the patients had an ABPI of less than 0.6 with half of the total     
patients reaching index less than 0.3. 
                                                           
 
ABPI 
 
No. 
 
Percent 
 
0 – 0.3 
 
51 
 
45.9% 
 
0.4 – 0.6 
 
44 
 
39.6% 
 
> 0.7 
 
9 
 
  8% 
 
Ischaemic heart disease: 
 
 
     Though only 17% of patients gave history of a previous cardiac event, 
evaluation of the patient in the ward with an ECG or echocardiogram revealed 
evidence of ischemia in about  30% of the patients. 
 
Pattern of vessel involvement:     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Using either color Doppler study or contrast digital subtraction angiogram, the 
level of block (complete or partial) was at the aortoiliac segment in 54% of the 
patients, while 35.5% had the disease in the iliofemoral segment.  18% of the 
 
Segment involved 
 
NO. 
 
Percentage 
 
Aortoiliac segment 
 
60 
 
  54.1% 
 
Iliofemoral segment 
 
35 
 
  31.5% 
 
Multiple levels 
 
18 
 
  16.2% 
patients had multiple level obstructions starting from aortoiliac segment 
downwards. 
 
 
Radiological evidence of level of the inflow obstruction was compared with the 
clinically assessment of blood flow (absent or weak pulse).  No significant 
difference was found between the two. 
 
Management of the patients with Aortoiliac occlusive disease: 
 
• Conservative management:             26.1% 
 
• Intervention rate :                               87.3% 
                                           Operative revascularization              - 42    (38.5%) 
                                            Radiological   intervention               - 25    (22.5%) 
                                            Primary amputation/ Debridement   - 30    (27%) 
 
 
Level of block   % patients    Details 
Clinical 
examination 
      
      87 % 
Femoral pulse absent in 75% 
 and weakly palpable in 12% of patients 
Radiological 
diagnosis 
       
     86.1 % 
Aortoiliac segment involved in 51.4% and 
Iliofemoral segment involved in 31.5% 
        38.5% of the patients underwent operative revascularization, either a aorto-
femoral bypass or a ilio-femoral bypass graft.  22.5% of the patients received 
radiological revascularization including PTA and stenting of the occluded 
segment under guidance of digital subtraction angiography.  Another 27% 
underwent some degree of primary amputation / debridement resulting in tissue 
loss.  Two patients underwent combined radiological and operative 
revascularization.                                   
 
                                                                                                           
Treatment outcome: 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
Pain relief 
 
     No. 
 
Percentage 
 
Operative revascularization 
 
     35   (42) 
 
83.3% 
 
Radiological intervention 
 
    19   (25) 
 
76% 
 
Palpable pulse 
 
   No. 
 
Percentage  
 
Operative revascularization 
 
   36 (42)    
 
85.7% 
 
Radiological intervention 
 
   21 (25) 
 
84   % 
  
The improvement in the ABPI and post procedure palpable pulses were 
calculated specific to the intervention provided. In the operative revascularization 
group, pulse was palpable post op in about 86%, and there was improvement in 
the ABPI in 93% of patients.  84% had satisfactory pain relief among these 
patients.  In the group which received radiological intervention, the pulse returned 
in 84% and ABPI improved in 88% of patients.  86% had relief from pain.  
Healing of the ulcers could not be completely evaluated during the stay in 
hospital, nevertheless, signs of healing was seen in 63% of patients.  Healing 
was worse in those consuming tobacco (33%) and those with diabetes (37%). 
 
Complications: 
 
       Complications were tabulated again specific to the intervention.  Of the 25 
patients who underwent radiological intervention, 7 developed procedure related 
 
Improved ABPI 
 
No. 
 
Percentage 
 
Operative revascularization 
 
39 (42) 
 
93% 
 
Radiological intervention 
 
22 (25) 
 
88% 
complications i.e. dissection of the vessel or post procedure thrombosis of the 
vessel (24%).   
 
In the operative revascularization group, 5 of the 42 patients developed graft 
thrombosis requiring either revision or subsequent amputation (11.9%).  3% of 
total patients finally developed gangrene regardless of the treatment modality.  
An overall 15% underwent amputation or debridement after any of the above 
treatment, including conservatively managed patients. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                    
                                                 CONCLUSIONS 
 
This observational study has revealed following important conclusions 
 
1. The previously known risk factors play vital role in pathogenesis and 
progression of the atherosclerotic vascular disease.  The major factors 
found in this study were: 
2.  
           Modifiable:                                      Non-modifiable: 
          Tobacco consumption                       Advancing age 
           Diabetes mellitus                              Male gender 
           Hypertension 
           Dyslipidaemia 
 
In order to stop the disease process and prevent further progression, 
these modifiable factors need to be aggressively identified and treated.  
Tobacco use, in any form, should be strongly discouraged. 
 
3. Majority of the patients (64%) with Aortoiliac disease presented with 
critical ischemia and the rest (36%) complained only of claudication.  
 
4. Ischemic heart disease was major comorbidity when other systems 
were  affected by atherosclerosis.  This was followed by impotence                          
and almost equal number of patients had a cerebral vascular ischemic 
event.  This observation further emphasizes the importance of strict 
risk factor control on a preventive basis.   
 
5. The undernourishment was probably due to reduced food intake 
secondary to chronic pain and morbidity. Typical features of limb 
ischemia, namely trophic changes and coldness of the affected limb 
were seen in almost all the patients. 
 
6.   Ischemia was at critical level, as indicated by ABPI of < 0.3, in about 
half the patients.  Majority of patients (91%) had ABPI of   < 0.6. 
 
7. Radiological evaluation correlated well with the clinical examination in 
determining the pattern of the vessel involvement.  
Most patients had block in the aortoiliac segment.  A small proportion 
of the patients also had blocks at multiple levels. 
 
8. Most of the patients had some form of intervention – operative or 
radiological revascularization.   
              
 
 
 
9. About one third of the patients required only conservative treatment     
including antiplatelet therapy, which is very important in the 
management of any occlusive disease of the arteries. 
 
10. About one third of the patient had tissue loss in form of amputation or  
debridement.   
   This was at a higher rate in the patients with diabetes and who 
    consume tobacco. These two factors also delayed the signs of ulcer 
    healing. 
 
11. Both surgical and radiological interventions, in the appropriately 
chosen patients, had comparable results with respect to post 
procedure palpable pulse, improvement in ABPI and in giving patients 
relief from the ischemic pain. 
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